[Inhibition activity of Scutellariae barbata extracts against human hepatocellular carcinoma cells]

Jing-ming Lin1, Yu Liu, Rong-cheng Luo

  • 1Department of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China.

Abstract

Insights

Scutellariae barbata extracts show potential in inhibiting human hepatocellular carcinoma cell growth. These extracts induce apoptosis and alter cell cycle progression, offering a novel therapeutic avenue.

Area of Science:

  • Pharmacology
  • Oncology
  • Molecular Biology

Background:

  • Hepatocellular carcinoma (HCC) remains a significant global health challenge.
  • Identifying novel therapeutic agents for HCC is crucial.

Purpose of the Study:

  • To evaluate the inhibitory effects of Scutellariae barbata extracts on the proliferation of the QGY-7701 human HCC cell line.
  • To elucidate the underlying mechanisms of action.

Main Methods:

  • MTT assay to assess cell proliferation inhibition.
  • Microscopy for observing morphologic changes.
  • Flow cytometry for cell cycle distribution, apoptosis analysis, and gene expression (Bcl-2, Bax, Fas).

Main Results:

  • Scutellariae barbata extracts significantly inhibited QGY-7701 cell proliferation.
  • Induced morphologic changes indicative of early apoptosis.
  • Increased apoptotic cells and altered cell cycle distribution (decreased G0/G1, increased G2/M).
  • Modulated expression of apoptosis-related genes: upregulated Bax, downregulated Bcl-2, with no change in Fas.

Conclusions:

  • Scutellariae barbata extracts demonstrate anti-proliferative effects on HCC cells.
  • Mechanisms involve Bcl-2 activation, apoptosis induction, and cell cycle arrest.
  • Potential for Scutellariae barbata as a therapeutic agent against HCC.

Related Concept Videos